You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The test will identify more than 100 pathogens, as well as drug resistance in viruses and bacteria.
GeneCapture's platform would allow medical providers of all skill levels to quickly treat bacterial infections with the appropriate antibiotics in remote environments
The kit, developed by BGI Patho-Genesis Pharmaceutical Technology, is designed to construct a metagenomic sequencing library directly from clinical samples.
BioFire has submitted a 39-target test to the US Food and Drug Administration. OpGen also has a test in development.
The funding is part of a BARDA contract worth up to $72 million to support the development of a test to diagnose acute infection at the point of care.
Inflammatix said that if its test obtains Emergency Use Authorization next year, clinicians will be able to better gauge the severity of a COVID-19 patient's infection.
The company plans to use the funding to expand operations in Florida and California and continue commercial growth of its FebriDx test.
The company's RaPID platform detects infections directly from a blood sample and can provide results in three hours.
In December the firm won $4 million from CARB-X to support the platform's first test identifying the most common bloodstream infections associated with sepsis.
The first year's pilot phase aimed to develop an infectious disease digital health and precision medicine platform connecting healthcare facilities to NYSDOH.